MediClin Forecast, price target & analysts
MediClin Target price 2025 - Analyst rating & recommendation
MediClin Classifications & Recommendation:
MediClin Price Target
| Target Price | €4.79 |
| Price | €3.44 |
| Potential |
39.36%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target MediClin 2026 .
The average MediClin target price is €4.79.
This is
39.36%
register free of charge
€5.15
49.56%
register free of charge
€4.55
32.12%
register free of charge
|
|
| A rating was issued by 6 analysts: 5 Analysts recommend MediClin to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MediClin stock has an average upside potential 2026 of
39.36%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 765.08 | 780.84 |
| 0.22% | 2.06% | |
| EBITDA Margin | 14.43% | 13.85% |
| 5.62% | 3.99% | |
| Net Margin | 3.25% | 3.84% |
| 330.93% | 18.27% |
3 Analysts have issued a sales forecast MediClin 2025 . The average MediClin sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an MediClin EBITDA forecast 2025. The average MediClin EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 MediClin Analysts have issued a net profit forecast 2025. The average MediClin net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.52 | 0.63 |
| 326.09% | 21.15% | |
| P/E | 5.45 | |
| EV/Sales | 0.53 |
3 Analysts have issued a MediClin forecast for earnings per share. The average MediClin EPS is
This results in the following potential growth metrics and future valuations:
Current MediClin Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| SOLVENTIS RESEARCH |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| SOLVENTIS RESEARCH |
Locked
➜
Locked
|
Locked | May 08 2025 |
| SOLVENTIS RESEARCH |
Locked
➜
Locked
|
Locked | May 07 2025 |
| DZ BANK |
Locked
➜
Locked
|
Locked | Apr 22 2025 |
| DZ BANK |
Locked
➜
Locked
|
Locked | Apr 21 2025 |
| SOLVENTIS RESEARCH |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| SOLVENTIS RESEARCH |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
SOLVENTIS RESEARCH:
Locked
➜
Locked
|
Aug 08 2025 |
|
Locked
SOLVENTIS RESEARCH:
Locked
➜
Locked
|
May 08 2025 |
|
Locked
SOLVENTIS RESEARCH:
Locked
➜
Locked
|
May 07 2025 |
|
Locked
DZ BANK:
Locked
➜
Locked
|
Apr 22 2025 |
|
Locked
DZ BANK:
Locked
➜
Locked
|
Apr 21 2025 |
|
Locked
SOLVENTIS RESEARCH:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
SOLVENTIS RESEARCH:
Locked
➜
Locked
|
Apr 01 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
